ESROKAST-L Tablets combine Levocetirizine Dihydrochloride (5 mg) and Montelukast Sodium (10 mg) for powerful relief from respiratory allergies, asthma, and seasonal allergic rhinitis. This clinically proven dual-action formula works by blocking histamine to reduce allergic symptoms and preventing airway inflammation to improve breathing comfort.
Form: Uncoated Tablet
Composition (per tablet):
Levocetirizine Dihydrochloride IP – 5 mg
Montelukast Sodium IP – 10 mg
Colour: Titanium Dioxide IP
Pack Size: 10 × 10 Tablets
MRP: ₹149/-
Adults & Adolescents (12 years and above): 1 tablet once daily in the evening or as directed by a physician.
Children: Dose to be determined by the doctor based on age and weight.
✔ Relieves sneezing, itching, runny nose & watery eyes
✔ Prevents airway inflammation and asthma symptoms
✔ Controls both seasonal & perennial allergies
✔ Convenient once-daily dosing
✔ Suitable for long-term allergy management under medical supervision
Trusted Quality – Manufactured in WHO-GMP-certified facilities
Scientifically Formulated – Clinically proven ingredients for effective results
Affordable Healthcare – Competitive pricing without compromising quality
Wide Product Range – Covering multiple therapeutic segments for better patient care
Strong Distribution Network – Ensuring timely product availability across India
